Cardiac Rhythm Management Devices | Market Insights | US | 2024
The US market for cardiac rhythm management devices will grow through 2032, with trends varying by device segment. The COVID19 global pandemic had a negative impact on some CRM procedure volumes in 2020, followed by a period of recovery. Growth in
market revenue will be driven by increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However,
increasing competition in the leadless pacemaker and S-ICD markets will put downward pressure on prices and consequently limit
growth to some extent.
This Medtech 360 Report provides comprehensive data and analysis on the state of the US cardiac rhythm management device
market from 2019 through 2032.